The Application Notebook
Akzo Nobel
Polypeptide hormones play key endocrine functions in humans. In particular, angiotensins are oligopeptide hormones, critical in the regulation of body fluids which ultimately affect blood pressure levels in individuals. A UHPLC method based on reversed-phase chromatography was created for the analysis of angiotensins using EternityXT C18 UHPLC columns, which can work under a wide range of pH and withstand exposure to solutions of NaOH beyond typical clean-in-place conditions.
The sample mixture used in this study consisted of three angiotensins:
Angiotensin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
Angiotensin II Asp-Arg-Val-Tyr-Ile-His-Pro-Phe
Angiotensin III Arg-Val-Tyr-Ile-His-Pro-Phe
These samples were analyzed under low and high pH reversed phase gradient chromatography.
Low pH conditions: mobile phase A 0.1% TFA in water (pH 1.9), mobile phase B 0.1% TFA in acetonitrile, gradient 0 min 9% B, 10 min 36% B, flow rate 0.7 mL/min, monitored at 220 nm.
High pH conditions: mobile phase A 0.1% ammonium hydroxide in water (pH 11.0), mobile phase B acetonitrile, gradient 0 min 5% B, 10 min 40% B, flow rate 0.7 mL/min, monitored at 225 nm.
Figure 1: Separation of Angiotensin I, II, and III using a 50 Ã 2.1 mm EternityXT 1.8-C18 column. Conditions (low pH): mobile phase A 0.1% TFA in water (pH 1.9), mobile phase B 0.1% TFA in acetonitrile, gradient 0 min 9% B, 10 min 36% B, flow rate 0.7 mL/min, detection UV @ 220 nm. Conditions (high pH): mobile phase A 0.1% ammonium hydroxide in water (pH 11.0), mobile phase B acetonitrile, gradient 0 min 5% B, 10 min 40% B, flow rate 0.7 mL/min, detection UV @ 225 nm.
Chromatographic retention changes and selectivity under low and high pH conditions were evaluated using EternityXT UHPLC C18 for the separation of angiotensins under linear gradient reversed phase conditions. Figure 1 shows two chromatographic results, the top chromatogram was obtained using pH 1.9, while the bottom chromatogram resulted from using pH 11. As seen in the figure, while the mixture used in this study contained three peptides, the analysis at pH 1.9 resulted in a co-elution of two out of three compounds. On the other hand, by increasing the pH of the mobile phase to 11, complete resolution among the three peaks was achieved. Further, evaluating the top and bottom chromatographic results, it is seen that selectivity reversal between Antiotensin I and III can occur by adjusting the pH of the analysis. Finally, the results shown in the figure illustrate the utility of using EternityXT UHPLC columns where a wide range of pH can be explored to achieve the best separation possible and to benefit analysts working with oligopeptides in the laboratory.
AkzoNobel
Strawinskylaan 2555, 1077 ZZ Amsterdam, The Netherlands
Tel: +31 20 502 7555
Website: www.akzonobel.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.